Octarine Bio
DenmarkEntry
2026
Hold
New
Status
Active
Who owns Octarine Bio?
Octarine Bio is a Danish Biotech company, currently owned by The Footprint Firm since 2026 and Unconventional Ventures.
Hand-verified · updated 2026-08-18
Open JSON · CC-BYMost recent investor
The Footprint FirmFootprint Fund I · 2023 · VC
2 ownership periods · full history below
Key facts
HQDenmark
SectorBiotech
StatusActive
Ownership history
2 ownership periods
Active
Unconventional VenturesActive
2023 · present(3yr) · Fund I · 2022 · VC
The Footprint FirmActive
2026 · present(<1yr) · Footprint Fund I · 2023 · VC
More from Footprint Fund I
Other portfolio companies in the same fund.
Spain
Sweden
Norway
NetherlandsMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Octarine Bio?
Octarine Bio is currently owned by The Footprint Firm and Unconventional Ventures, through Footprint Fund I, since 2026.
When did The Footprint Firm and 1 other acquire Octarine Bio?
The Footprint Firm and 1 other acquired Octarine Bio in 2026.
Who has owned Octarine Bio over time?
Octarine Bio has been through 2 private-equity ownership periods: Unconventional Ventures · via Fund I · since 2023; The Footprint Firm · via Footprint Fund I · since 2026.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue